Rottenburg, Germany

Michael Bitzer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Bitzer: Innovator in Tumor Treatment Technologies

Introduction

Michael Bitzer is a notable inventor based in Rottenburg, Germany. He has made significant contributions to the field of medical technology, particularly in the treatment of tumor diseases. With a total of 3 patents to his name, Bitzer's work focuses on innovative approaches to combat cancer.

Latest Patents

One of his latest patents is for a genetically modified paramyxovirus aimed at treating tumor diseases. This invention includes a pharmaceutical composition that utilizes the paramyxovirus for therapeutic and prophylactic treatment of tumor conditions. Another significant patent is for an oncolytic measles virus, which comprises a recombinant measles virus encoding a suicide gene. This invention is designed for treating malignant cells that exhibit primary or secondary resistance against an oncolytic measles virus without suicide gene activity.

Career Highlights

Throughout his career, Michael Bitzer has worked with esteemed institutions, including Eberhard Karls University Tuebingen and its associated University Hospital. His research and innovations have positioned him as a key figure in the development of advanced cancer therapies.

Collaborations

Bitzer has collaborated with notable professionals in his field, including Ulrich Manfred Lauer and Sascha Bossow. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Michael Bitzer's innovative work in the field of tumor treatment technologies showcases his dedication to improving cancer therapies. His contributions through patented inventions reflect a commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…